Currently approved monoamine modulating antidepressant and anxiolytic pharmaceutics fail in over one third of patients due to delayed and variable therapeutic effect, adverse reactions preceding the t
Background : Depression and anxiety are psychiatric disorders that are related to tobacco use and associated with dependence, the process of cessation, lapses and relapses after quitting smoking.
Patients with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, often have comorbid anxiety and depression that affects their quality of life (QoL) and management of
